It has more significant weight loss effects and lowers heart rate and blood pressure than Diethylpropion
Follow-up care : Ask about follow-up care in case of any concerns or complications after the treatment
Larsens weight loss program has a goal to help you develop better eating habits that will stick with you after finish the program
The titration regimen described in the NEJM 2023 obesity trial (Jastreboff et al.) progressed as follows: Weeks 14 : 2 mg once weekly Weeks 58 : 4 mg once weekly Weeks 912 : 8 mg once weekly Week 12 onwards : Up to 12 mg once weekly (in higher-dose cohorts) This regimen was used exclusively within a regulated clinical trial setting and does not constitute an approved dosing schedule
Orlistat, one of the most well-known PL inhibitors, offers a case study on the effectiveness, challenges, and side effects associated with this therapeutic approach [24]
Excess weight increases the risk of type 2 diabetes, high blood pressure, heart disease, fatty liver disease, sleep apnea, joint pain, stroke, and some cancers